Preliminary unaudited fourth quarter 2023 net revenue is expected to be $37.6 million, representing growth of 21% compared to $31.0 million in the fourth quarter of 2022. Preliminary domestic fourth quarter net revenue is expected to be $28.3 million, representing 24% growth compared to the prior year period, and international net revenue is expected to be $9.3 million, representing 13% growth compared to the prior year period.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on KIDS:
- OrthoPediatrics Corp. Announces Preliminary Unaudited Financial Highlights for the Fourth Quarter & Full Year 2023
- OrthoPediatrics Corp. Announces Acquisition of Boston Orthotics & Prosthetics
- OrthoPediatrics price target raised to $39 from $35 at Truist
- OrthoPediatrics price target lowered to $50 from $60 at JMP Securities
- OrthoPediatrics announces launch of specialty bracing division
